CSIMarket Company Name, Ticker, Customers, else..
 
• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Twist Bioscience Corporation  (NASDAQ: TWST)
Other Ticker:  
 

Twist Bioscience's Working Capital Per Sales

TWST's Working Capital and Revenue growth

 



TWST Working Capital Per Revenue (Mar 31 2025)
II. Quarter		 (Dec 31 2024)
I. Quarter		 (Sep 30 2024)
IV. Quarter		 (Jun 30 2024)
III. Quarter		 (Mar 31 2024)
II. Quarter
Y / Y Working Capital Change -13.44 % -15.18 % -21.42 % -22.71 % -27.04 %
Y / Y Revenue Change 23.23 % 24.08 % 26.53 % 27.81 % 25.13 %
Working Capital Per Revenue 0.79 0.87 0.95 1.07 1.22
Working Capital Per Revenue Ranking # 1830 # 2604 # 2593 # 2660 # 2749
Seq. Working Capital Change -4.42 % -0.04 % -4.27 % -5.36 % -6.35 %
Seq. Revenue Change 4.6 % 4.73 % 3.98 % 8.18 % 5.32 %


New: More TWST's historic Working Capital Per Revenue Ratios >>


Financial strength information for the Biotechnology & Pharmaceuticals industry >> Back to TWST Financial Strength Comparisons >> See TWST Balance Sheets

Comment on TWST's Working Capital Per Revenue in the second quarter 2025
Twist Bioscience's Working Capital Per Revenue in the Q2 2025 sequentially fell to 0.79 a new company low.

Within Healthcare sector 32 other companies have achieved lower Working Capital Per Revenue during the Q2 2025. While Twist Bioscience Working Capital Per Revenue overall ranking has impoved so far in the Q2 2025 to 1830, from total ranking in the first quarter 2024 at 2604.
Working Capital Per Revenue Ranking
Within: No.
Industry # 6
Sector # 33
S&P 500 # 1830


Working Capital Per Revenue Statistics
High Average Low
27.12
3.38
0.79
(Dec 31 2018)   (Mar 31 2025)



Financial Statements
Twist Bioscience's Working Capital $ 263 Millions Visit TWST's Balance sheet
Twist Bioscience's Revenues $ 93 Millions Visit TWST's Income Statement
Where are TWST's Sales coming from? Visit TWST's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2025, within Healthcare Sector Working Capital Per Revenue
Humacyte Inc   2.10 
Outset Medical Inc   2.06 
Amarin Corp Plcuk  2.04 
Cvrx inc   2.04 
Moderna Inc   2.03 
Butterfly Network Inc   2.00 
Oncocyte Corporation  1.99 
Arvinas Inc   1.98 
Maravai Lifesciences Holdings Inc   1.98 
Rhythm Pharmaceuticals inc   1.94 
Krystal Biotech Inc   1.92 
Orasure Technologies Inc  1.92 
Scpharmaceuticals Inc   1.92 
Assembly Biosciences Inc   1.90 
Tenon Medical Inc  1.89 
Omniab Inc   1.87 
Invivyd Inc   1.87 
Rxsight Inc   1.79 
Pacific Health Care Organization Inc  1.77 
Iovance Biotherapeutics inc   1.76 
Arcturus Therapeutics Holdings Inc   1.72 
Meiragtx Holdings Plc  1.69 
Theravance Biopharma inc   1.67 
Schrodinger Inc   1.67 
Vanda Pharmaceuticals Inc   1.65 
Cytek Biosciences Inc   1.65 
Personalis Inc   1.64 
Sight Sciences Inc   1.60 
Zai Lab Limited  1.59 
Cryoport inc   1.57 
Date modified: 2025-05-06T08:12:15+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com